BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gooding I, Dondos V, Gyi KM, Hodson M, Westaby D. Variceal hemorrhage and cystic fibrosis: Outcomes and implications for liver transplantation. Liver Transpl 2005;11:1522-6. [DOI: 10.1002/lt.20465] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Ye W, Narkewicz MR, Leung DH, Karnsakul W, Murray KF, Alonso EM, Magee JC, Schwarzenberg SJ, Weymann A, Molleston JP; CFLDnet research group. Variceal Hemorrhage and Adverse Liver Outcomes in Patients With Cystic Fibrosis Cirrhosis. J Pediatr Gastroenterol Nutr 2018;66:122-7. [PMID: 28906321 DOI: 10.1097/MPG.0000000000001728] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
2 Van Biervliet S, Verdievel H, Vande Velde S, De Bruyne R, De Looze D, Verhelst X, Geerts A, Robberecht E, Van Vlierberghe H. Longitudinal Transient Elastography Measurements Used in Follow-up for Patients with Cystic Fibrosis. Ultrasound in Medicine & Biology 2016;42:848-54. [DOI: 10.1016/j.ultrasmedbio.2015.11.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
3 Squires RH, Ng V, Romero R, Ekong U, Hardikar W, Emre S, Mazariegos GV. Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Hepatology. 2014;60:362-398. [PMID: 24782219 DOI: 10.1002/hep.27191] [Cited by in Crossref: 101] [Cited by in F6Publishing: 77] [Article Influence: 12.6] [Reference Citation Analysis]
4 Kappler M, Espach C, Schweiger-Kabesch A, Lang T, Hartl D, Hector A, Glasmacher C, Griese M. Ursodeoxycholic acid therapy in cystic fibrosis liver disease--a retrospective long-term follow-up case-control study. Aliment Pharmacol Ther 2012;36:266-73. [PMID: 22670841 DOI: 10.1111/j.1365-2036.2012.05177.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
5 Faro A, Weymann A. Transplantation. Pediatric Clinics of North America 2016;63:709-34. [DOI: 10.1016/j.pcl.2016.04.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Lu BR, Esquivel CO. A review of abdominal organ transplantation in cystic fibrosis. Pediatr Transplant 2010;14:954-60. [PMID: 20946451 DOI: 10.1111/j.1399-3046.2010.01412.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
7 Nash KL, Collier JD, French J, McKeon D, Gimson AE, Jamieson NV, Wallwork J, Bilton D, Alexander GJ. Cystic fibrosis liver disease: to transplant or not to transplant? Am J Transplant 2008;8:162-9. [PMID: 17973959 DOI: 10.1111/j.1600-6143.2007.02028.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
8 Kochar R, Fallon MB. Pulmonary Diseases and the Liver. Clinics in Liver Disease 2011;15:21-37. [DOI: 10.1016/j.cld.2010.09.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
9 Sasame A, Stokes D, Bourke B, Connolly L, Fitzpatrick E, Rowland M. The impact of liver disease on mortality in cystic fibrosis-A systematic review. J Cyst Fibros 2021:S1569-1993(21)01328-X. [PMID: 34380590 DOI: 10.1016/j.jcf.2021.07.014] [Reference Citation Analysis]
10 Arnon R, Annunziato RA, Miloh T, Padilla M, Sogawa H, Batemarco L, Willis A, Suchy F, Kerkar N. Liver and combined lung and liver transplantation for cystic fibrosis: Analysis of the UNOS database: Liver transplantation for cystic fibrosis. Pediatric Transplantation 2011;15:254-64. [DOI: 10.1111/j.1399-3046.2010.01460.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
11 Rowland M, Gallagher CG, O'Laoide R, Canny G, Broderick A, Hayes R, Greally P, Slattery D, Daly L, Durie P, Bourke B. Outcome in cystic fibrosis liver disease. Am J Gastroenterol 2011;106:104-9. [PMID: 20736939 DOI: 10.1038/ajg.2010.316] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
12 Palaniappan SK, Than NN, Thein AW, Moe S, van Mourik I. Interventions for preventing and managing advanced liver disease in cystic fibrosis. Cochrane Database Syst Rev 2017;8:CD012056. [PMID: 28850173 DOI: 10.1002/14651858.CD012056.pub2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
13 Valamparampil JJ, Gupte GL. Cystic fibrosis associated liver disease in children. World J Hepatol 2021; 13(11): 1727-1742 [PMID: 34904041 DOI: 10.4254/wjh.v13.i11.1727] [Reference Citation Analysis]
14 Debray D, Kelly D, Houwen R, Strandvik B, Colombo C. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. J Cyst Fibros. 2011;10 Suppl 2:S29-S36. [PMID: 21658639 DOI: 10.1016/s1569-1993(11)60006-4] [Cited by in Crossref: 233] [Cited by in F6Publishing: 69] [Article Influence: 21.2] [Reference Citation Analysis]
15 Gelfond D, Borowitz D. Gastrointestinal complications of cystic fibrosis. Clin Gastroenterol Hepatol. 2013;11:333-342; quiz e30-e31. [PMID: 23142604 DOI: 10.1016/j.cgh.2012.11.006] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 5.2] [Reference Citation Analysis]
16 Pals F, Verkade H, Gulmans V, De Koning B, Koot B, De Meij T, Hendriks D, Gierenz N, Vreugdenhil A, Houwen R, Bodewes F. Cirrhosis associated with decreased survival and a 10-year lower median age at death of cystic fibrosis patients in the Netherlands. Journal of Cystic Fibrosis 2019;18:385-9. [DOI: 10.1016/j.jcf.2018.11.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
17 Messick J. A 21st-century approach to cystic fibrosis: optimizing outcomes across the disease spectrum. J Pediatr Gastroenterol Nutr 2010;51 Suppl 7:S1-7; quiz 3 p following S7. [PMID: 20739870 DOI: 10.1097/MPG.0b013e3181ec0242] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Costaguta A, Alvarez F. Etiology and management of hemorrhagic complications of portal hypertension in children. Int J Hepatol 2012;2012:879163. [PMID: 23097711 DOI: 10.1155/2012/879163] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
19 Nash E, Volling C, Gutierrez C, Tullis E, Coonar A, Mcrae K, Keshavjee S, Singer L, Durie P, Chaparro C. Outcomes of patients with cystic fibrosis undergoing lung transplantation with and without cystic fibrosis-associated liver cirrhosis*: Lung transplant with CF liver cirrhosis. Clinical Transplantation 2012;26:34-41. [DOI: 10.1111/j.1399-0012.2010.01395.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
20 Herrmann U, Dockter G, Lammert F. Cystic fibrosis-associated liver disease. Best Pract Res Clin Gastroenterol. 2010;24:585-592. [PMID: 20955961 DOI: 10.1016/j.bpg.2010.08.003] [Cited by in Crossref: 55] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
21 Ooi CY, Durie PR. Cystic fibrosis from the gastroenterologist's perspective. Nat Rev Gastroenterol Hepatol 2016;13:175-85. [DOI: 10.1038/nrgastro.2015.226] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 10.8] [Reference Citation Analysis]
22 Colombo C. Liver disease in cystic fibrosis. Curr Opin Pulm Med. 2007;13:529-536. [PMID: 17901760 DOI: 10.1097/mcp.0b013e3282f10a16] [Cited by in Crossref: 115] [Cited by in F6Publishing: 36] [Article Influence: 8.2] [Reference Citation Analysis]
23 Squires JE, McKiernan P. Molecular Mechanisms in Pediatric Cholestasis. Gastroenterol Clin North Am. 2018;47:921-937. [PMID: 30337041 DOI: 10.1016/j.gtc.2018.07.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
24 Zhang KY, Tung BY, Kowdley KV. Liver Transplantation for Metabolic Liver Diseases. Clinics in Liver Disease 2007;11:265-81. [DOI: 10.1016/j.cld.2007.04.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
25 Sakiani S, Kleiner DE, Heller T, Koh C. Hepatic Manifestations of Cystic Fibrosis. Clin Liver Dis 2019;23:263-77. [PMID: 30947876 DOI: 10.1016/j.cld.2018.12.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
26 Vo HD, Xu J, Rabinowitz SS, Fisher SE, Schwarz SM. The Liver in Pediatric Gastrointestinal Disease. Journal of Pediatric Gastroenterology & Nutrition 2014;59:288-99. [DOI: 10.1097/mpg.0000000000000444] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
27 Moyer K, Balistreri W. Hepatobiliary disease in patients with cystic fibrosis. Curr Opin Gastroenterol 2009;25:272-8. [PMID: 19381084 DOI: 10.1097/MOG.0b013e3283298865] [Cited by in Crossref: 67] [Cited by in F6Publishing: 15] [Article Influence: 5.2] [Reference Citation Analysis]
28 Sasame A, Connolly L, Fitzpatrick E, Stokes D, Bourke B, Rowland M. The impact of liver disease on mortality in cystic fibrosis - a systematic review protocol. HRB Open Res 2020;3:44. [PMID: 33305166 DOI: 10.12688/hrbopenres.13065.3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Sasame A, Connolly L, Fitzpatrick E, Stokes D, Bourke B, Rowland M. The impact of liver disease on mortality in cystic fibrosis - a systematic review protocol. HRB Open Res 2020;3:44. [PMID: 33305166 DOI: 10.12688/hrbopenres.13065.3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Al Sinani S, Al-Mulaabed S, Al Naamani K, Sultan R. Cystic Fibrosis Liver Disease: Know More. Oman Med J 2019;34:482-9. [PMID: 31745411 DOI: 10.5001/omj.2019.90] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Riggio O, Gioia S, Pentassuglio I, Nicoletti V, Valente M, d'Amati G. Idiopathic noncirrhotic portal hypertension: current perspectives. Hepat Med. 2016;8:81-88. [PMID: 27555800 DOI: 10.2147/hmer.s85544] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
32 Rowland M, Bourke B. Liver disease in cystic fibrosis. Curr Opin Pulm Med 2011;17:461-6. [PMID: 21881510 DOI: 10.1097/MCP.0b013e32834b7f51] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
33 Jonas MM. The role of liver transplantation in cystic fibrosis re-examined. Liver Transpl 2005;11:1463-5. [DOI: 10.1002/lt.20571] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
34 Nightingale S, O'Loughlin EV, Dorney SF, Shun A, Verran DJ, Strasser SI, McCaughan GW, Jermyn V, Van Asperen P, Gaskin KJ, Stormon MO. Isolated liver transplantation in children with cystic fibrosis--an Australian experience. Pediatr Transplant 2010;14:779-85. [PMID: 20557476 DOI: 10.1111/j.1399-3046.2010.01341.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
35 Leeuwen L, Fitzgerald DA, Gaskin KJ. Liver disease in cystic fibrosis. Paediatr Respir Rev. 2013;Jun 13; Epub ahead of print. [PMID: 23769887 DOI: 10.1016/j.prrv.2013.05.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
36 Palaniappan SK, Than NN, Thein AW, van Mourik I. Interventions for preventing and managing advanced liver disease in cystic fibrosis. Cochrane Database Syst Rev 2020;3:CD012056. [PMID: 32227478 DOI: 10.1002/14651858.CD012056.pub3] [Reference Citation Analysis]
37 Boëlle PY, Debray D, Guillot L, Clement A, Corvol H; French CF Modifier Gene Study Investigators. Cystic Fibrosis Liver Disease: Outcomes and Risk Factors in a Large Cohort of French Patients. Hepatology 2019;69:1648-56. [PMID: 30058245 DOI: 10.1002/hep.30148] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 9.5] [Reference Citation Analysis]
38 Rowland M, Gallagher C, Gallagher CG, Laoide RÓ, Canny G, Broderick AM, Drummond J, Greally P, Slattery D, Daly L, McElvaney NG, Bourke B. Outcome in patients with cystic fibrosis liver disease. J Cyst Fibros 2015;14:120-6. [PMID: 24917116 DOI: 10.1016/j.jcf.2014.05.013] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]